We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

60 hedge funds and large institutions have $553M invested in Foghorn Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

64% more capital invested

Capital invested by funds: $338M → $553M (+$215M)

28% more funds holding

Funds holding: 47 → 60 (+13)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.42% less ownership

Funds ownership: 65.73% → 65.31% (-0.42%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

73% less call options, than puts

Call options by funds: $949K | Put options by funds: $3.52M

Holders
60
Holders Change
+13
Holders Change %
+27.66%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
20
Increased
13
Reduced
16
Closed
7
Calls
$949K
Puts
$3.52M
Net Calls
-$2.57M
Net Calls Change
-$2.57M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.51M
2
EI
EAM Investors
California
+$2.15M
3
EGI
EAM Global Investors
California
+$1.48M
4
DCM
Driehaus Capital Management
Illinois
+$1.29M
5
State Street
State Street
Massachusetts
+$1.11M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$6.14M
2
MIM
Monashee Investment Management
Massachusetts
-$4.18M
3
CC
Casdin Capital
New York
-$3M
4
KCM
Kingdon Capital Management
New York
-$2.18M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$837K -$94.7K -6,587 -12%
Goldman Sachs
27
Goldman Sachs
New York
$833K +$340K +23,634 +185%
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$595K +$374K +26,000 New
CSS
29
Cubist Systematic Strategies
Connecticut
$488K +$307K +21,336 New
Bank of America
30
Bank of America
North Carolina
$458K +$115K +8,033 +67%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$445K +$14.1K +979 +5%
JGC
32
J. Goldman & Co
New York
$429K -$701K -48,762 -72%
SS
33
Sunbelt Securities
Texas
$334K +$356K +24,740 New
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$324K +$204K +14,168 New
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$312K -$661 -46 -0.3%
RJA
36
Raymond James & Associates
Florida
$296K +$186K +12,937 New
Deutsche Bank
37
Deutsche Bank
Germany
$272K -$1.19M -83,055 -87%
HSBC Holdings
38
HSBC Holdings
United Kingdom
$267K -$130K -9,056 -44%
Wells Fargo
39
Wells Fargo
California
$250K +$157K +10,914 New
FT
40
Fiduciary Trust
Massachusetts
$249K – – –
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$245K -$9.53K -663 -6%
AIG
42
American International Group
New York
$238K -$4.47K -311 -3%
MIM
43
MetLife Investment Management
New Jersey
$199K – – –
JP Morgan Chase
44
JP Morgan Chase
New York
$172K -$60.3K -4,192 -36%
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$162K +$22.6K +1,571 +28%
UBS Group
46
UBS Group
Switzerland
$158K +$99.1K +6,893 New
MLICM
47
Metropolitan Life Insurance Company (MetLife)
New York
$150K – – –
Simplex Trading
48
Simplex Trading
Illinois
$126K +$79.7K +5,548 New
Citigroup
49
Citigroup
New York
$114K +$39.6K +2,756 +124%
SM
50
SG3 Management
Puerto Rico
$114K +$71.9K +5,000 New
1
2
3

FHTX Hedge Fund Activity: Q4 2021 in Review

60 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q4 2021, worth a combined $553M — up 64% from $338M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FHTX positions and 7 closed out — a net gain of 13 holders — while 13 added to existing stakes and 16 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $5.51M. The largest seller was Morgan Stanley, cutting an estimated $6.14M.

  • 60 institutional investors held Foghorn Therapeutics (FHTX) as of Q4 2021, up from 47 in Q3 2021.
  • Funds reported $553M of Foghorn Therapeutics stock for Q4 2021, up 64% quarter-over-quarter.
  • 20 funds opened new Foghorn Therapeutics positions in Q4 2021 and 7 closed out, a net change of +13 holders.
  • The largest Foghorn Therapeutics buyer in Q4 2021 was Point72 Asset Management, an estimated $5.51M added.
  • The largest Foghorn Therapeutics seller in Q4 2021 was Morgan Stanley, an estimated $6.14M sold.

Based on aggregated 13F filings for Q4 2021.